BRK-B vs HBT
Valuation
Profitability
Growth
Financial Health
Dividends
AI Verdict
The deterministic health profile is weak, highlighted by a Piotroski F-Score of 3/9, indicating deteriorating operational efficiency and profitability trends. While the company maintains a fortress balance sheet with a Debt/Equity ratio of 0.19 and a Current Ratio of 7.07, the stock is trading at a significant premium to its growth-based intrinsic value of $217.21. Negative YoY revenue and earnings growth, coupled with a bearish technical trend, offset the positive analyst sentiment and long-term historical performance.
HBT presents a conflicting profile with a stable Piotroski F-Score of 4/9 and a Graham Number ($32.79) suggesting undervaluation, yet an Intrinsic Value ($17.08) that indicates significant overvaluation. While the company maintains a strong track record of earnings beats and a sustainable dividend, current growth metrics are concerning with negative YoY earnings growth (-6.30%). The bearish insider sentiment and low technical trend score offset the positive analyst recommendations, suggesting a period of stagnation or correction.
Compare Another Pair
Related Comparisons
BRK-B vs HBT: Head-to-Head Comparison
This page compares Berkshire Hathaway Inc. (BRK-B) and HBT Financial, Inc. (HBT) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.
Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.